ONIVYDE (Irinotecan Liposome)

About Medicine

  • Name: ONIVYDE
  • Generic Name: Irinotecan Liposome
  • Strength: 43 mg/10 mL
  • Company: Merrimack Pharmaceuticals, Inc.
  • Packing: Single-dose vial
Get Price
Categories: ,

Description

Onivyde – Irinotecan Liposome 43 mg/ 10 ml is supplied for Tenders, Emergency imports, Orphan drug, Reference listed drugs, Comparator Drug, Name patient medicine, Bio-Similar and Innovator samples etc.

(ONIVYDE is registered trademarks Merrimack Pharmaceuticals, Inc.)

What is ONIVYDE:

ONIVYDE is a medicine that contains the active substance Irinotecan Liposome and is available as Single-dose vial.

In how many countries ONIVYDE 43 mg/10 mL is approved for marketing?

ONIVYDE is available/approved in USA and Europe. We can help you to access it in India.

What is ONIVYDE 43 mg/10 mL used for?

ONIVYDE is indicated, in combination with fluorouracil and leucovorin, for the treatment of patients with metastatic adenocarcinoma of the pancreas after disease progression following gemcitabine-based therapy.

How can I get ONIVYDE 43 mg/10 mL in India?

ONIVYDE is a prescription only drug and is not approved for marketing in India.

The Indian Pharma (IP) is a consulting pharmaceutical company which assists Patients in accessing medicines in India. The Indian Pharma facilitates such access only against valid prescriptions in conformity with all local laws and regulations.

Patients/ Clinicians / Researchers can contact IP at +91-120-4080562 or write to at –info@theindianpharma.com

We facilitate by-

  • Helping in documentation to import the medicine for personal use
  • Finding Genuine and reliable source in USA, Europe and Japan
  • Ensuring 100% transparency.

ONIVYDE can be shipped to Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Jaipur, Lucknow, Cochin and Pune and other cities in India.

The Indian Pharma can facilitate the supply of ONIVYDE 43 mg/10 mL (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement.

The Indian Pharma does not manufacture, supply, re-sell or retail any drugs or medicines. All trademarks and other intellectual property in relation to drugs and medicines supplied to you by suppliers are owned by their respective manufacturers or licensees

Commonly asked questions

Can I get ONIVYDE 43 mg/10 mL even if I am not based in India?

Almost all countries across the world have provisions for granting access to drugs prior to marketing approval for personal use for patients who have exhausted all other treatment options available in their country

The Indian Pharma (IP) can help patients in accessing/importing ONIVYDE, unapproved in their home country against a legitimate prescription and in conformity with all local laws and regulations of their home country.

Send your enquiry to find-

  • ONIVYDE in South East Asia – China (Beijing, Chongqing, Shanghai, Tianjin and Shenzhen), Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong.
  • ONIVYDE in United Arab Emirates – Iraq, Iran, Saudi Arabia, Jordan.
  • ONIVYDE in North America – Mexico.
  • ONIVYDE in South America – Argentina, Brazil, Chile, Colombia, Peru, Venezuela.
  • ONIVYDE in Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia.
  • ONIVYDE in Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia.
  • ONIVYDE in African Countries – Algeria, Mauritius, Uganda, Zimbabwe.
  • ONIVYDE in Australia and New Zealand.

How is ONIVYDE 43 mg/10 mL used?

ONIVYDE should be administered under the guidance of specialist doctor having experience in managing cancer treatments.

Recommended dose: ONIVYDE is 70 mg/m2 intravenous infusion over 90 minutes every two weeks. If the patient develops certain serious side effects then doctor may interrupt or stop treatment, or reduce the dose. See the summary of product characteristics on company official website for more information

Are there any side-effects/ adverse reactions/precautions associated with treatment with ONIVYDE? It is recommended to seek your doctor’s medical advice about side effects

How do I contact The Indian Pharma?

You can use different channel to contact The Indian Pharma (IP) Tele & Mobile: You can reach us on +91 8826990915 or +91-120-4080562 on any working day. Email: We can also address your enquiries if sent directly to info@theindianpharma.com. We will respond within 24 hours after receiving your mail. Please mention detailed enquiry, your contact number with ISD code while sending your mail. We will respond within 1 working days after receiving your query form.

Documentation

What information do you need to help patient in assisting documentation for ONIVYDE 43 mg/10 mL import for personal use?

We will require the following documents to help in documentation for Named-Patient import

  • Doctor’s Prescription – We would require prescription from Registered Medical Practitioner Stating Product name, dosage, duration of treatment and diagnosis
  • Patient’s Medical history – We would require all test reports and Medical reports of the patient for last 3 months.
  • Patient’s Identity card – We will require scan copy of Patient’s identity card and proof of residence to initiate documentation process. You can use copy of Passport, Driving License, Employee ID card or any Photo ID document as your Identity card.

Related products

× How can I Help you?